Rossmax International Ltd. (TPEX:4121)

Market Cap	1.29B
Revenue (ttm)	3.85B
Net Income (ttm)	-29.35M
Shares Out	85.49M
EPS (ttm)	-0.34
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (3.30%)
Ex-Dividend Date	Jun 12, 2024

Volume	153,278
Average Volume	339,288
Open	15.30
Previous Close	15.15
Day's Range	15.10 - 15.30
52-Week Range	11.65 - 23.95
Beta	0.48
RSI	52.66
Earnings Date	May 9, 2025

About Rossmax International

Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds of an animal or human body; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1988
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4121

Financial Performance

In 2024, Rossmax International's revenue was 3.85 billion, an increase of 1.11% compared to the previous year's 3.81 billion. Losses were -29.35 million, 340.3% more than in 2023.